Versatility of gene therapy vectors through viruses
- 1 May 2005
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 5 (5), 639-662
- https://doi.org/10.1517/14712598.5.5.639
Abstract
Several viruses have been engineered for gene therapy applications, and the specific properties of each viral vector have been exploited to target a variety of inherited and acquired diseases. Preclinical and clinical studies demonstrated that viral vectors are highly versatile tools capable of efficient transfer of foreign genetic information into almost all cell types and tissues. Gene therapy applications depend on vector characteristics, such as host range, cell- or tissue-specific targeting, genome integration, efficiency and duration of transgene expression, packaging capacity, and suitability for scale-up pr-oduction. This review discusses the advances in the development of viral vectors, with particular emphasis on how knowledge of virus biology has been exploited to design a variety of vectors with improved safety ch-aracteristics and efficiency, potentially suitable for a large number of gene therapy applications.Keywords
This publication has 98 references indexed in Scilit:
- Toolbox for retrovectorologistsThe Journal of Gene Medicine, 2004
- Occurrence of leukaemia following gene therapy of X-linked SCIDNature Reviews Cancer, 2003
- Progress and problems with the use of viral vectors for gene therapyNature Reviews Genetics, 2003
- Infectious Delivery of 120-Kilobase Genomic DNA by an Epstein–Barr Virus Amplicon VectorMolecular Therapy, 2002
- Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion geneGene Therapy, 2001
- The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brainNature Biotechnology, 2001
- Effect of Protease Inhibitors on Yield of HSV-1-Based Viral VectorsBiotechnology Progress, 2000
- High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and CapGene Therapy, 1999
- Use of EBV-Based Vector/HVJ-Liposome Complex Vector for Targeted Gene Therapy of EBV-Associated NeoplasmsBiochemical and Biophysical Research Communications, 1997
- A 5′ element of the chicken β-globin domain serves as an insulator in human erythroid cells and protects against position effect in DrosophilaCell, 1993